Kristina Behnke

Kristina Behnke

Auto-generated profile, based on publicly available information

Kristina Behnke

Institute of Biochemistry and Molecular Biology II, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
Stefanie Dichtl-ZweimüllerStefanie Dichtl-Zweimüller
Stefanie Dichtl-Zweimüller
LLLaura Lindenthal
Laura Lindenthal
LZLeonie Zeitler
Leonie Zeitler
KBKristina Behnke
Kristina Behnke
DSDaniela Schlösser
Daniela Schlösser
PMPeter J. Murray
Peter J. Murray
Inflammation induces macrophage histone lactylation uncoupled from arginine metabolism or M2 polarization.

29 October 2019 in Science Signaling
Verified
Journal Article
Closed access
PDF file
BSBalamurugan Sundaram
Balamurugan Sundaram
KBKristina Behnke
Kristina Behnke
ABAndrea Belancic
Andrea Belancic
MAMazin Al-Salihi
Mazin Al-Salihi
YTYasser Thabet
Yasser Thabet
PLPhilipp A. Lang
Philipp A. Lang
Chronic liver disease can induce prolonged activation of hepatic stellate cells, which may result in liver fibrosis. Inactive rhomboid protein 2 (iRhom2) is required for the maturation of A disintegrin and metalloprotease 17 (ADAM17, also called TACE), which is responsible for the cleavage of membrane-bound tumor necrosis factor–α (TNF-α) and its receptors (TNFRs). Here, using the murine bile duct ligation (BDL) model, we showed that the abundance of iRhom2 and activation of ADAM17 increased during liver fibrosis. Consistent with this, concentrations of ADAM17 substrates were increased in plasma samples from mice after BDL and in patients suffering from liver cirrhosis. We observed increased liver fibrosis, accelerated disease progression, and an increase in activated stellate cells after BDL in mice lacking iRhom2 (Rhbdf2−/−) compared to that in controls. In vitro primary mouse hepatic stellate cells exhibited iRhom2-dependent shedding of the ADAM17 substrates TNFR1 and TNFR2. In vivo TNFR shedding after BDL also depended on iRhom2. Treatment of Rhbdf2−/− mice with the TNF-α inhibitor etanercept reduced the presence of activated stellate cells and alleviated liver fibrosis after BDL. Together, these data suggest that iRhom2-mediated inhibition of TNFR signaling protects against liver fibrosis.

5 February 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
LGLinda Große-Segerath
Linda Große-Segerath
PFPaula Follert
Paula Follert
KBKristina Behnke
Kristina Behnke
JEJulia Ettich
Julia Ettich
TBTobias Buschmann
Tobias Buschmann
ELEckhard Lammert
Eckhard Lammert
Recently, we have shown that after partial hepatectomy (PHx), an increased hepatic blood flow initiates liver growth in mice by vasodilation and mechanically-triggered release of angiocrine signals. Here, we use mass spectrometry to identify a mechanically-induced angiocrine signal in human hepatic endothelial cells, that is, myeloid-derived growth factor (MYDGF). We show that it induces proliferation and promotes survival of primary human hepatocytes derived from different donors in two-dimensional cell culture, via activation of mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription 3 (STAT3). MYDGF also enhances proliferation of human hepatocytes in three-dimensional organoids. In vivo, genetic deletion of MYDGF decreases hepatocyte proliferation in the regenerating mouse liver after PHx; conversely, adeno-associated viral delivery of MYDGF increases hepatocyte proliferation and MAPK signaling after PHx. We conclude that MYDGF represents a mechanically-induced angiocrine signal and that it triggers growth of, and provides protection to, primary mouse and human hepatocytes.

14 April 2023 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
PRPuyan Rafii
Puyan Rafii
FRFriedrich Reusswig
Friedrich Reusswig
JWJulia Werner
Julia Werner
HXHaifeng Xu
Haifeng Xu
PLPhilipp A. Lang
Philipp A. Lang
KBKristina Behnke
Kristina Behnke
IL-6 family members contribute to host defense through the stimulation of acute-phase signaling, hematopoiesis, immune reactions, and regenerative processes. To investigate essential mechanisms that are linked toward a constitutively activated gp130 signaling, we generated and characterized a mouse model that reflects a constitutive and cytokine-independent activation of JAK/STAT3 signaling by Lgp130 in CD4- and CD8-positive T cells. Lgp130 is an engineered form of gp130 in which dimerization and activation are forced by a leucine zipper. T cell–specific Lgp130 activation resulted in massive phenotypical abnormalities, including splenomegaly, lymphadenopathy, and an upregulation of innate immune system components shown by hyperinflammatory signatures in several organs. Moreover, T cell–restricted expression of Lgp130 resulted in increased numbers of cytotoxic and regulatory T cells, especially in lymph nodes. Consistent with this, we found an elevated platelet production and increase in megakaryocytes in the spleen and bone marrow that are causative for an acute thrombocytosis accompanied by anemia. Due to a shortened life span of T cell–specific Lgp130 mice, we could also show that next to an overall increase in regulatory cell-cycle genes, an activation of p53 and increased expression of p21 provide evidence for a senescence-like phenotype. Together, these data suggest that T cell–restricted gp130 activation is not only involved in autoimmune processes but also in senescence-associated aging. Therefore, Lgp130 expression in T cells might be a suitable model to study inflammation and disease.